GB1349362A - Process for preparing live virus vaccines - Google Patents
Process for preparing live virus vaccinesInfo
- Publication number
- GB1349362A GB1349362A GB1085371A GB1085371A GB1349362A GB 1349362 A GB1349362 A GB 1349362A GB 1085371 A GB1085371 A GB 1085371A GB 1085371 A GB1085371 A GB 1085371A GB 1349362 A GB1349362 A GB 1349362A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccines
- virus
- april
- virus vaccines
- live virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000700605 Viruses Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 241000286209 Phasianidae Species 0.000 abstract 2
- 208000000655 Distemper Diseases 0.000 abstract 1
- 208000006758 Marek Disease Diseases 0.000 abstract 1
- 208000005647 Mumps Diseases 0.000 abstract 1
- 208000010359 Newcastle Disease Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 206010046865 Vaccinia virus infection Diseases 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000037797 influenza A Diseases 0.000 abstract 1
- 208000037798 influenza B Diseases 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 208000010805 mumps infectious disease Diseases 0.000 abstract 1
- 201000005404 rubella Diseases 0.000 abstract 1
- 208000007089 vaccinia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3527470A JPS5013333B1 (enrdf_load_stackoverflow) | 1970-04-22 | 1970-04-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1349362A true GB1349362A (en) | 1974-04-03 |
Family
ID=12437194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1085371A Expired GB1349362A (en) | 1970-04-22 | 1971-04-22 | Process for preparing live virus vaccines |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5013333B1 (enrdf_load_stackoverflow) |
| BE (1) | BE766093A (enrdf_load_stackoverflow) |
| CA (1) | CA955850A (enrdf_load_stackoverflow) |
| CH (1) | CH563459A5 (enrdf_load_stackoverflow) |
| DE (1) | DE2119688C3 (enrdf_load_stackoverflow) |
| FR (1) | FR2092068B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1349362A (enrdf_load_stackoverflow) |
| IT (1) | IT1001467B (enrdf_load_stackoverflow) |
| NL (2) | NL173598C (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA743771B (en) * | 1973-07-19 | 1975-07-30 | M Sevoian | Vaccine and preparation thereof |
-
1970
- 1970-04-22 JP JP3527470A patent/JPS5013333B1/ja active Pending
-
1971
- 1971-04-02 FR FR7111805A patent/FR2092068B1/fr not_active Expired
- 1971-04-03 IT IT2272771A patent/IT1001467B/it active
- 1971-04-21 CA CA110,999A patent/CA955850A/en not_active Expired
- 1971-04-22 BE BE766093A patent/BE766093A/xx unknown
- 1971-04-22 NL NL7105497A patent/NL173598C/xx not_active IP Right Cessation
- 1971-04-22 DE DE2119688A patent/DE2119688C3/de not_active Expired
- 1971-04-22 CH CH589371A patent/CH563459A5/xx not_active IP Right Cessation
- 1971-04-22 GB GB1085371A patent/GB1349362A/en not_active Expired
-
1983
- 1983-09-09 NL NL8303134A patent/NL8303134A/nl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IT1001467B (it) | 1976-04-20 |
| DE2119688B2 (de) | 1979-08-09 |
| BE766093A (fr) | 1971-09-16 |
| DE2119688C3 (de) | 1980-04-24 |
| FR2092068B1 (enrdf_load_stackoverflow) | 1977-04-15 |
| CA955850A (en) | 1974-10-08 |
| CH563459A5 (enrdf_load_stackoverflow) | 1975-06-30 |
| JPS5013333B1 (enrdf_load_stackoverflow) | 1975-05-19 |
| NL173598B (nl) | 1983-09-16 |
| NL8303134A (nl) | 1984-01-02 |
| NL173598C (nl) | 1984-02-16 |
| FR2092068A1 (enrdf_load_stackoverflow) | 1972-01-21 |
| NL7105497A (enrdf_load_stackoverflow) | 1971-10-26 |
| DE2119688A1 (de) | 1971-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4071618A (en) | Process for preparing virus disease live vaccines | |
| Maassab et al. | Laboratory and clinical characteristics of attenuated strains of influenza virus | |
| GB1183506A (en) | New vaccines for combating influenza and the preparation thereof | |
| DE3889138D1 (de) | Influenza-Impfstoff. | |
| GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
| ES373631A1 (es) | Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. | |
| GB1317710A (en) | Poultry vaccine | |
| US3961046A (en) | Mumps vaccine and preparation thereof | |
| GB1349362A (en) | Process for preparing live virus vaccines | |
| US3429965A (en) | Avian pox virus vaccine and process of preparing same | |
| Takemoto et al. | Influence of acid polysaccharides on plaque formation by influenza A2 and B viruses | |
| KR880001808A (ko) | 닭의 전염병(전염성 후두기관염 및 마렉크병) 생 왁진 | |
| JPH0998778A (ja) | マレク病ワクチン | |
| MacFarlane et al. | Cultivation of toxoplasma in the developing chick embryo. | |
| GB1274820A (en) | Highly attenuated newcastle disease virus vaccine and production thereof | |
| US4112068A (en) | Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom | |
| Buddingh | The chick embryo for the study of infection and immunity | |
| Mack et al. | Serological response in chickens to beta-propiolactone treated Newcastle disease virus | |
| US3418210A (en) | Hamster ascites tumor cell line bhk 21/c.13/t.6/ascites useful in submerged serum-free agar cultures to support virus growth | |
| Melendez et al. | Multiplication of foot and mouth disease virus in adult kidney, and embryonic lung and heart bovine tissue cultures | |
| GB1358321A (en) | Method od tissue cell culture | |
| KR840001215A (ko) | 개량된 변종균주의 제법 | |
| GB1015262A (en) | Virus culture | |
| GB1279859A (en) | Process for the production of enhanced levels of viral yield | |
| GB1324618A (en) | Infectious coryza infectious bronchitis and newcastle disease vaccines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |